Genmab A (GMAB) FCF Margin (2018 - 2026)
Genmab A (GMAB) posted FCF Margin of 0.33% for Q1 2026, down 98.99% on a QoQ basis from 33.25% in Q3 2025, and down 3981.0% year-over-year from 0.01% in Q1 2025.
Genmab A (GMAB) FCF Margin (2018 - 2026) Analysis & Trends
Genmab A's FCF Margin history runs 6 years deep, the most recent figure standing at 0.33% for Q1 2026.
- Quarterly FCF Margin fell 3981.0% year-over-year to 0.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.92% (down 893.0% YoY) and the FY2025 annual result came in at 30.89%, down 519.0% from the prior year.
- FCF Margin was 0.33% for Q1 2026 at Genmab A, down from 33.25% in the prior quarter.
- Across five years, FCF Margin topped out at 40.14% in Q1 2025 and bottomed at 0.33% in Q1 2026.
- A 3-year average of 28.08% and a median of 33.25% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2025 — FCF Margin surged 382 bps — and 2026, when it sank 3981 bps.
- Genmab A's FCF Margin stood at 33.53% in 2024, then retreated by 1 bps to 33.25% in 2025, then sank by 99 bps to 0.33% in 2026.
- Business Quant data shows GMAB's FCF Margin at 0.33% in Q1 2026, 33.25% in Q3 2025, and 21.28% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | 0.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.33% |
| Sep 30, 2025 | 33.25% |
| Jun 30, 2025 | 21.28% |
| Mar 31, 2025 | 40.14% |
| Sep 30, 2024 | 33.53% |
| Jun 30, 2024 | 31.69% |
| Mar 31, 2024 | 36.32% |
| Sep 30, 2020 | 0.00% |
| Dec 31, 2019 | 30.67% |
| Sep 30, 2019 | 30,684,218,017,317.98% |
| Dec 31, 2018 | 35.37% |